AzTrials
AzTrials

Knee OsteoarthritisNCT05453123

The Effect of Motivational Messages by "WhatsApp" on Adherence to Home Exercise Program

A study testing telerehabilitation in people with Knee Osteoarthritis, run by King Saud University at 1 site in Saudi Arabia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to examine the effect of the text message platform (WhatsApp) on the adherence to home exercise programs, pain and physical function among middle age and older adults with knee OA in two public hospitals in Riyadh city, Saudi Arabia Read more about this study

Who is it for?
Ages 45 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Knee Osteoarthritis
What is being tested?
telerehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteSaudi Arabia
Study dates
Jul 2022to 28 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Saudi adults aged 45 to 65. Diagnosis of unilateral or bilateral, mild to moderate knee OA

Who cannot join

  • Diagnosis of severe knee OA Diagnosis of neurological conditions Diagnosis of cardiopulmonary conditions Diagnosis of mental disorders on wait for surgical intervention.

Trial locations and contacts

1 site in 1 country.

lujain pt aldahash, master contact

+966540850997 ext. 12211

inoon@outlook.sa

hanaa dr alsobayl, profoser contact

Saudi Arabia1 site, 1 recruiting
  • King Saud University

    Riyadh

    king saud university, +966-11) 469-1531, mailto:rdeocampo@ksu.edu.sa

    Recruiting

Other trials in Saudi Arabia

About this study

Official title: The Effect of Motivational Messages by "WhatsApp" on Adherence to Home Exercise Program Among Middle-aged and Older Adults With Knee Osteoarthritis in Saudi Arabia

This study aims to examine the effect of the text message platform (WhatsApp) on the adherence to home exercise programs, pain and physical function among middle age and older adults with knee OA in two public hospitals in Riyadh city, Saudi Arabia

Being tested
telerehabilitation
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • telerehabilitationBehavioural

    examine the effect of the text message platform (WhatsApp) on the adherence to home exercise programs, pain and physical function among middle age and older adults with knee OA in two public hospitals in Riyadh city, Saudi Arabia.

Study groups in NCT05453123
Study groupRoleWhat they receive
paper-handout armActive comparatorthe paper-handout arm is the control group taking the home exercise printed in the paper handout.
Receives: Behavioral: telerehabilitation
intervention armExperimentalthe intervention arm is the experimental group where they take home exercise and motivational text messages by WhatsUp
Receives: Behavioral: telerehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence percentage outcome was measured with the self-report

    The participants received an online exercise log via WhatsApp message and were asked to record the date and number of the exercise session

    Measured: baseline and see the change after 6 weeks

Secondary outcomes (2)
  1. VAS

    a single-item continuous scale composed of a horizontal or vertical line (Hawker et al., 2011). The score is determined by measuring the distance (in mm) on a 10-cm line between the "no pain" (score of 0) anchor and the patient's mark (evaluating their pain), providing a range of scores from 0-to 10. A higher score of 10 indicates higher pain intensity.

    Measured: baseline and see the change after 6 weeks

  2. WOMAC

    The WOMAC is a disease-specific self-report instrument with 17 items in Physical Function. It has been extensively used; it is valid, reliable, and widely recommended in studies of individuals with knee OA, (score range 0-68 where 68 indicates worse function.

    Measured: baseline and see the change after 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2022
  2. Study startJul 2022 (estimated)
  3. Primary completion1 Aug 2022 (estimated)
  4. Study completion28 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05453123
Sponsor's protocol ID
kneeOA
Status last verified
Jul 2022
First submitted
29 Jun 2022
Last updated
12 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Eickenberg H-U. Letter: Hypoazotemia. Urology. 1975 Aug;6(2):267. doi: 10.1016/0090-4295(75)90734-7. No abstract available.

    PubMed 1145951
  • Al-Arfaj AS, Al-Boukai A. Prevalence of radiographic osteoarthritis of the hands in Saudi Arabia. Rheumatol Int. 2002 Sep;22(5):208-12. doi: 10.1007/s00296-002-0228-5. Epub 2002 Aug 13.

    PubMed 12215868

Questions about this trial

What is this clinical trial studying?

A study testing telerehabilitation in people with Knee Osteoarthritis, run by King Saud University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact lujain pt aldahash, master (+966540850997 ext. 12211, inoon@outlook.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence percentage outcome was measured with the self-report (time frame: baseline and see the change after 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05453123, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in